| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.27 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.17 | 0.4 |